| Primary |
| Type 2 Diabetes Mellitus |
48.7% |
| Diabetes Mellitus |
30.8% |
| Contraception |
2.6% |
| Dyslipidaemia |
2.6% |
| Hyperlipidaemia |
2.6% |
| Hypertension |
2.6% |
| Hypertriglyceridaemia |
2.6% |
| Insomnia |
2.6% |
| Oral Candidiasis |
2.6% |
| Vulvovaginal Candidiasis |
2.6% |
|
| Pancreatitis |
21.4% |
| Rash |
10.7% |
| Pancreatic Carcinoma |
7.1% |
| Angina Pectoris |
3.6% |
| Constipation |
3.6% |
| Diarrhoea |
3.6% |
| Dizziness |
3.6% |
| Drug Ineffective |
3.6% |
| Drug Interaction |
3.6% |
| Headache |
3.6% |
| Lung Neoplasm Malignant |
3.6% |
| Myalgia |
3.6% |
| No Adverse Event |
3.6% |
| Pancreatitis Acute |
3.6% |
| Pharyngeal Oedema |
3.6% |
| Rash Maculo-papular |
3.6% |
| Renal Failure Acute |
3.6% |
| Rhabdomyolysis |
3.6% |
| Rhinitis |
3.6% |
| Sinusitis |
3.6% |
|
| Secondary |
| Product Used For Unknown Indication |
33.3% |
| Drug Use For Unknown Indication |
22.0% |
| Diabetes Mellitus |
12.1% |
| Type 2 Diabetes Mellitus |
11.3% |
| Irritability |
4.0% |
| Hypertension |
3.7% |
| Hypersensitivity |
1.7% |
| Gastrooesophageal Reflux Disease |
1.4% |
| Arthralgia |
1.1% |
| Asthma |
1.1% |
| Blood Glucose Increased |
1.1% |
| Blood Pressure |
0.8% |
| Depression |
0.8% |
| Diabetes Mellitus Non-insulin-dependent |
0.8% |
| Herpes Zoster |
0.8% |
| Hypercholesterolaemia |
0.8% |
| Liver Disorder |
0.8% |
| Pain In Extremity |
0.8% |
| Chest Pain |
0.6% |
| Dementia Alzheimer's Type |
0.6% |
|
| Completed Suicide |
24.4% |
| Death |
8.5% |
| Pancreatitis |
8.5% |
| Rhabdomyolysis |
7.3% |
| Vision Blurred |
4.9% |
| Melaena |
3.7% |
| Palpitations |
3.7% |
| Pemphigoid |
3.7% |
| Poisoning |
3.7% |
| Renal Failure Acute |
3.7% |
| Toxicity To Various Agents |
3.7% |
| Weight Decreased |
3.7% |
| Weight Increased |
3.7% |
| Alanine Aminotransferase Increased |
2.4% |
| Blood Glucose Abnormal |
2.4% |
| Blood Glucose Increased |
2.4% |
| Cytolytic Hepatitis |
2.4% |
| Diarrhoea |
2.4% |
| Drug Toxicity |
2.4% |
| Drug-induced Liver Injury |
2.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
23.8% |
| Diabetes Mellitus |
17.2% |
| Drug Use For Unknown Indication |
14.6% |
| Hypertension |
10.2% |
| Type 2 Diabetes Mellitus |
8.0% |
| Pain |
3.4% |
| Rheumatoid Arthritis |
2.8% |
| Depression |
2.4% |
| Smoking Cessation Therapy |
2.4% |
| Blood Cholesterol Increased |
2.3% |
| Atrial Fibrillation |
2.1% |
| Chronic Obstructive Pulmonary Disease |
1.9% |
| Anxiety |
1.5% |
| Hypercholesterolaemia |
1.2% |
| Coronary Artery Disease |
1.2% |
| Prophylaxis |
1.2% |
| Osteoarthritis |
1.1% |
| Erectile Dysfunction |
1.0% |
| Fibromyalgia |
0.9% |
| Diabetic Neuropathy |
0.9% |
|
| Weight Decreased |
10.3% |
| Weight Increased |
9.3% |
| Vomiting |
8.2% |
| Blood Glucose Increased |
7.7% |
| Nausea |
7.7% |
| Drug Ineffective |
6.7% |
| Death |
5.2% |
| Thrombocytopenia |
4.1% |
| Urticaria |
4.1% |
| Vertigo |
4.1% |
| Haemoglobin Decreased |
3.6% |
| Pain In Extremity |
3.6% |
| Rheumatoid Arthritis |
3.6% |
| Loose Tooth |
3.1% |
| Oedema Peripheral |
3.1% |
| Renal Failure Acute |
3.1% |
| Somnolence |
3.1% |
| Urinary Tract Infection |
3.1% |
| Vision Blurred |
3.1% |
| Visual Acuity Reduced |
3.1% |
|
| Interacting |
| Product Used For Unknown Indication |
37.5% |
| Diabetes Mellitus |
20.0% |
| Type 2 Diabetes Mellitus |
10.0% |
| Anticoagulant Therapy |
5.0% |
| Diabetes Mellitus Management |
5.0% |
| Hypercholesterolaemia |
5.0% |
| Hypertension |
5.0% |
| Mineral Supplementation |
5.0% |
| Atrial Fibrillation |
2.5% |
| Cerebrovascular Accident |
2.5% |
| Glaucoma |
2.5% |
|
| Drug Interaction |
53.3% |
| Rhabdomyolysis |
26.7% |
| Nausea |
6.7% |
| Nervousness |
6.7% |
| Vision Blurred |
6.7% |
|
